Cargando…
Actionable pharmacogenetic markers for prediction and prognosis in breast cancer
Breast cancer is a heterogeneous disease that necessitates proper patient classification to direct surgery, pharmacotherapy, and radiotherapy. Despite patients within the same subgroup receiving similar pharmacotherapy, substantial variation in clinical outcomes is observed. Pharmacogenetic variatio...
Autores principales: | Sacco, Keith, Grech, Godfrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511448/ https://www.ncbi.nlm.nih.gov/pubmed/26203310 http://dx.doi.org/10.1186/s13167-015-0037-z |
Ejemplares similares
-
Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico
por: Gonzalez-Covarrubias, Vanessa, et al.
Publicado: (2019) -
Pharmacogenetics of FSH Action in the Male
por: Schubert, Maria, et al.
Publicado: (2019) -
Pharmacogenetics of FSH Action in the Female
por: Conforti, Alessandro, et al.
Publicado: (2019) -
Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management
por: Rofaiel, Sarah, et al.
Publicado: (2010) -
Clinical Application of Pharmacogenetic Markers in the Treatment of Dermatologic Pathologies
por: Membrive Jiménez, Cristina, et al.
Publicado: (2021)